This is an outdated version published on 2022-06-30. Read the most recent version.

Efficacy and tolerability of Nitazoxanide for intestinal parasitism in schoolchildren treated at the Health Center of the University of Quindío


Authors

  • Humberto Alejandro Nati Castillo Universidad del Quindío https://orcid.org/0000-0003-1890-4983
  • Jorge Andrés Montes Cardona Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL) https://orcid.org/0000-0003-1542-8512
  • Catalina Navarrete Ospina Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL) https://orcid.org/0000-0002-7120-7303
  • Paula Camila Aponte Morales Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL) https://orcid.org/0000-0002-8942-6694
  • Jorge Enrique Gómez Marín, phD Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL) https://orcid.org/0000-0001-6472-3329

DOI:

https://doi.org/10.22517/25395203.24955

Keywords:

Nitazoxanide, Giardiasis, Blastocystis, Efficacy, Tolerability

Abstract

Objective: To describe the effectiveness of the intestinal antiparasitic treatment given to children ranging between 4 and 9 years old that were attended in the Health Center of the University of Quindío in the period of July 2017 and March 2018. 

Materials and methods: Prospective observational study. Data were extracted from medical records of patients with an age range of 4 to 9 years, who consulted at the Health Center of the University of Quindío and were diagnosed through coprological tests with Blastocystis and Giardiasis. The clinical records were selected by whose treatment was done with Nitazoxanide or Albendazole with coprological results of post-treatment check-up. Descriptive statistics are presented along with percentage of efficacy and tolerability.

Results: From 15 children treated with Nitazoxanide, 10 responded to the treatment, who presented no parasites in the coprological check-up. The remaining population presented some type of parasitic infection (n = 5). With an efficiency of 83,3% (IC95% 32 – 82%) in blastocystis, and 57,1% (IC95% 32 – 82%) in giardiasis.

Conclusion: Percentage results similar to those reported in the literature were evidenced, being more effective in blastocystis than in giardiasis.

Downloads

Download data is not yet available.

Author Biographies

Humberto Alejandro Nati Castillo, Universidad del Quindío

Estudiante de medicina. Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL)

Jorge Andrés Montes Cardona, Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL)

Estudiante de medicina. Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL).

Catalina Navarrete Ospina, Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL)

Estudiante de medicina. Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL).

Paula Camila Aponte Morales, Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL)

Estudiante de medicina. Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL)

Jorge Enrique Gómez Marín, phD, Universidad del Quindío. Centro de Investigaciones Biomédicas, Grupo Parasitología Molecular (GEPAMOL)

Doctor en biología parasitaria

Docente.  Facultad Ciencias de la Salud, Universidad del Quindío

Downloads

Published

2022-02-14 — Updated on 2022-06-30

Versions

How to Cite

Nati Castillo, H. A., Montes Cardona, J. A., Navarrete Ospina, C., Aponte Morales, P. C., & Gómez Marín, J. E. (2022). Efficacy and tolerability of Nitazoxanide for intestinal parasitism in schoolchildren treated at the Health Center of the University of Quindío. Revista Médica De Risaralda, 28(1). https://doi.org/10.22517/25395203.24955 (Original work published February 14, 2022)